These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26481388)

  • 1. [Telephone enquiries on the topic of malignant hyperthermia: Evaluation of the content and subsequent diagnostic results at the MH Center Leipzig].
    Petersen B; Busch T; Meinecke CD; Börge B; Kluba K; Kaisers UX; Rüffert H
    Anaesthesist; 2016 Jan; 65(1):36-41. PubMed ID: 26481388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis of disposition for malignant hyperthermia--an updated review based on 1,001 studies].
    Olthoff D; Deutrich C; Meinecke CD
    Anaesthesiol Reanim; 1997; 22(2):32-40. PubMed ID: 9235003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group.
    Ording H; Brancadoro V; Cozzolino S; Ellis FR; Glauber V; Gonano EF; Halsall PJ; Hartung E; Heffron JJ; Heytens L; Kozak-Ribbens G; Kress H; Krivosic-Horber R; Lehmann-Horn F; Mortier W; Nivoche Y; Ranklev-Twetman E; Sigurdsson S; Snoeck M; Stieglitz P; Tegazzin V; Urwyler A; Wappler F
    Acta Anaesthesiol Scand; 1997 Sep; 41(8):955-66. PubMed ID: 9311391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors of the contracture test for diagnosing malignant hyperthermia in a Brazilian population sample: a retrospective observational study.
    de Mello JM; Andrade PV; Santos JM; Oliveira ASB; Vainzof M; do Amaral JLG; Almeida da Silva HC
    Braz J Anesthesiol; 2023; 73(2):145-152. PubMed ID: 35835312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current aspects of the diagnosis of malignant hyperthermia].
    Rüffert H; Olthoff D; Deutrich C; Froster UG
    Anaesthesist; 2002 Nov; 51(11):904-13. PubMed ID: 12434264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild clinical and histopathological features in patients who carry the frequent and causative malignant hyperthermia RyR1 mutation p.Thr2206Met.
    Rueffert H; Wehner M; Ogunlade V; Meinecke C; Schober R
    Clin Neuropathol; 2009; 28(6):409-16. PubMed ID: 19919814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of a positive malignant hyperthermia (MH) disposition without the in vitro contracture test in families carrying the RYR1 Arg614Cys mutation.
    Rueffert H; Olthoff D; Deutrich C; Froster UG
    Clin Genet; 2001 Aug; 60(2):117-24. PubMed ID: 11553045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro contracture test and gene typing in diagnosing malignant hyperthermia. Each as an appropriate complement to the other method].
    Rüffert H; Olthoff D; Deutrich C; Thamm B; Froster U
    Anaesthesist; 2000 Feb; 49(2):113-20. PubMed ID: 10756965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic testing for malignant hyperthermia susceptibility.
    Girard T; Treves S; Voronkov E; Siegemund M; Urwyler A
    Anesthesiology; 2004 May; 100(5):1076-80. PubMed ID: 15114203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis of malignant hyperthermia susceptibility. 1. The significance of in vitro susceptibility tests].
    Mortier W; Breucking E
    Anaesthesist; 1993 Oct; 42(10):675-83. PubMed ID: 8250201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the diagnosis of malignant hyperthermia susceptibility: how confident can we be of genetic testing?
    Robinson RL; Anetseder MJ; Brancadoro V; van Broekhoven C; Carsana A; Censier K; Fortunato G; Girard T; Heytens L; Hopkins PM; Jurkat-Rott K; Klinger W; Kozak-Ribbens G; Krivosic R; Monnier N; Nivoche Y; Olthoff D; Rueffert H; Sorrentino V; Tegazzin V; Mueller CR
    Eur J Hum Genet; 2003 Apr; 11(4):342-8. PubMed ID: 12700608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Israeli Diagnostic Center for Malignant Hyperthermia: 7-years' accumulated experience.
    Glauber V; Ben Abraham R; Zweig A; Perel A
    Isr J Med Sci; 1997 Oct; 33(10):643-7. PubMed ID: 9397136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Incidence of disposition for malignant hyperthermia in patients with neuromuscular diseases].
    Wappler F; Scholz J; von Richthofen V; Fiege M; Köchling A; Matschke J; Winkler G; Schulte am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Jun; 33(6):373-80. PubMed ID: 9689395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes.
    Robinson RL; Brooks C; Brown SL; Ellis FR; Halsall PJ; Quinnell RJ; Shaw MA; Hopkins PM
    Hum Mutat; 2002 Aug; 20(2):88-97. PubMed ID: 12124989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysis.
    Wappler F; Fiege M; Steinfath M; Agarwal K; Scholz J; Singh S; Matschke J; Schulte Am Esch J
    Anesthesiology; 2001 Jan; 94(1):95-100. PubMed ID: 11135728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant hyperthermia in Brazil: analysis of hotline activity in 2009.
    da Silva HC; Almeida Cdos S; Brandão JC; Nogueira e Silva CA; de Lorenzo ME; Ferreira CB; Resende AH; Barreira SR; de Almeida PA; Ferraro LH; Takeda A; de Oliveira KF; Lelis TG; Hortense A; Perez MV; Schmidt B; Oliveira AS; do Amaral JL
    Braz J Anesthesiol; 2013 Jan; 63(1):13-9. PubMed ID: 24565087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant Hyperthermia Susceptibility and Fitness for Duty.
    Lee MA; McGlinch EB; McGlinch MC; Capacchione JF
    Mil Med; 2017 Mar; 182(3):e1854-e1857. PubMed ID: 28290972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of National Anesthesia Workload on the Staffing of a Call Center: The Malignant Hyperthermia Consultant Hotline.
    Dexter F; Rosenberg H; Epstein RH; Semo JJ; Litman RS
    A A Case Rep; 2015 Aug; 5(3):43-6. PubMed ID: 26230307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Masseter muscle rigidity and the role of DNA analysis to confirm malignant hyperthermia susceptibility.
    Hudig K; Pollock N; Bulger T; Machon RG; Woodhead A; Schiemann AH; Stowell KM
    Anaesth Intensive Care; 2019 Jan; 47(1):60-68. PubMed ID: 30864471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant hyperthermia, a Scandinavian update.
    Broman M; Islander G; Müller CR
    Acta Anaesthesiol Scand; 2015 Sep; 59(8):951-61. PubMed ID: 25989378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.